Profile picture for user nka267

Neeraj Kapur, PhD

800 Rose St MN649


  • Assistant Professor

College Unit(s)

Other Affiliation(s)
  • Internal Medicine - Digestive Health

Selected Publications

Perry C, Kapur N, Barrett TA. DDP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use? Inflamm Bowel Dis. 2020 Jan 8.

Thomas JK, Mir H, Kapur N, and Singh S. Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer. Cancers (Basel). 2019 Nov 25;11(12).

Saunder IT, Mir H, Kapur N, and Singh S. Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. Cancer Cell Int. 2019 Apr 15:19-98.

Kapur N, Mir H, Sonpavde G, Jain S, Bae S, Lillard JW, and Singh S. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel. Cancer letters 2019 Apr 8;454:1- 13.

Thomas JK, Mir H, Kapur N, and Singh S. CC chemokines are differentially expressed in Breast Cancer and areassociated with disparity in overall survival. Scientific Reports 2019 Mar 8;9(1):4014.

Mir H, Kaur G, Kapur N, Bae S, Lillard JW, and Singh S. Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation. Scientific Reports 2019 Feb 21;9(1):2527.

Carriere PP, Kapur N, Mir H, Ward AB, Singh S. Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer. Int J Oncol. 2018 Oct;53(4):1442-1454.

Ward AB, Mir H, Kapur N, Gales DN, Carriere PP, Singh S. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting antiapoptotic pathways. World J Surg Oncol. 2018 Jun 14;16(1):108.

Kapur N, Mir H, Clark, III CE, Krishnamurti U, Beech DJ, Lillard Jr JW, Singh S. Higher CCR6 in colon cancer is associated with advanced disease and supports epithelial to mesenchymal transition. Brit. J Cancer, 2016; 114,1343-51.

Mir H, Kapur N, Singh R, Sonpavde G, Lillard Jr JW, Singh S. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors. Cell cycle, 2016; 15(6): 819-26.

Singh R, Kapur N, Mir H, Singh N, Lillard Jr JW, Singh S. CXCR6- CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via activating Ezrin and αvβ3 integrin clustering. Oncotarget, 2016; 7(6): 7343-53.

Panda SK, Kapur N, Paliwal D, Durgapal H. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers. J Nanobiotechnology, 2015; 13:44.

Paliwal D, Panda SK, Kapur N, Varma SP, Durgapal H. Hepatitis E Virus (HEV) Protease: a chymotrypsinlike enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein. J Gen Virol., 2014; 95(8):1689-700.

Kapur N, Thakral D, Durgapal H, Panda SK. Hepatitis E Virus (HEV) enters liver cell through receptor dependent clathrin-mediated endocytosis. J Viral Hepat., 2012; 19(6): 436-48.

Varma SP, Kumar A, Kapur N, Durgapal H, Acharya SK, Panda SK. Hepatitis E virus replication involves alternating negative- and positivesense RNA synthesis. J Gen Virol., 2011; 92: 572-81.

Rehman S, Kapur N, Durgapal H, Panda SK. Subcellular localization of hepatitis E virus (HEV) replicase. Virology, 2008; 370: 77-92.